Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Accelerate Diagnostics (GB:0H8E)
LSE:0H8E
Accelerate Diagnostics (0H8E) Stock Price & Analysis
0 Followers
0H8E Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.46 - $3.56
Previous Close$0.48
Volume0.00
Average Volume (3M)3.12K
Market Cap
$49.55M
Enterprise Value$71.06M
Total Cash (Recent Filing)$55.39M
Total Debt (Recent Filing)$76.90M
Price to Earnings (P/E)-0.5
Beta-0.08
Next Earnings
Mar 29, 2023EPS Estimate
-$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.97
Shares Outstanding99,099,480
10 Day Avg. Volume1,118
30 Day Avg. Volume3,120
Standard Deviation0.23
R-Squared0.04
Alpha-0.00308
Financial Highlights & Ratios
Price to Book (P/B)-4.92
Price to Sales (P/S)113.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.42
Enterprise Value/Gross Profit-186.52
Enterprise Value/Ebitda-1.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Accelerate Diagnostics News
0H8E FAQ
What was Accelerate Diagnostics’s price range in the past 12 months?
Accelerate Diagnostics lowest stock price was $0.46 and its highest was $3.56 in the past 12 months.
What is Accelerate Diagnostics’s market cap?
Currently, no data Available
When is Accelerate Diagnostics’s upcoming earnings report date?
Accelerate Diagnostics’s upcoming earnings report date is Mar 29, 2023 which is tomorrow.
How were Accelerate Diagnostics’s earnings last quarter?
Accelerate Diagnostics released its earnings results on Nov 14, 2022. The company reported -$0.167 earnings per share for the quarter, beating the consensus estimate of -$0.195 by $0.028.
Is Accelerate Diagnostics overvalued?
According to Wall Street analysts Accelerate Diagnostics’s price is currently Overvalued.
Does Accelerate Diagnostics pay dividends?
Accelerate Diagnostics does not currently pay dividends.
What is Accelerate Diagnostics’s EPS estimate?
Accelerate Diagnostics’s EPS estimate is -$0.15.
How many shares outstanding does Accelerate Diagnostics have?
Accelerate Diagnostics has 99,099,480 shares outstanding.
What happened to Accelerate Diagnostics’s price movement after its last earnings report?
Accelerate Diagnostics reported an EPS of -$0.167 in its last earnings report, beating expectations of -$0.195. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Accelerate Diagnostics?
Among the largest hedge funds holding Accelerate Diagnostics’s share is Oracle Investment Management Inc. It holds Accelerate Diagnostics’s shares valued at 1M.
---
Accelerate Diagnostics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.98%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.55%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Accelerate Diagnostics
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
---
Sensus Healthcare
―
Asensus Surgical
―
Co-Diagnostics
―
Owlet
―
Accelerate Diagnostics
―
---